Literature DB >> 19585493

Body mass index and mortality from lung cancer in smokers and nonsmokers: a nationally representative prospective study of 220,000 men in China.

Ling Yang1, Gonghuan Yang, Maigeng Zhou, Margaret Smith, Hui Ge, Jillian Boreham, Yisong Hu, Richard Peto, Jun Wang, Zhengming Chen.   

Abstract

Low body mass index (BMI) has been associated with increased risk of lung cancer. However, the nature of the association, especially in populations with relatively low BMI, is less well characterized, as is the relevance to it of smoking. A nationally representative prospective cohort study included 217,180 Chinese men aged 40-79 years in 1990-91 who had no prior history of cancer and were followed up for 15 years. Standardized hazard ratios (HRs) were calculated for lung cancer mortality by baseline BMI. The mean baseline BMI was 21.7 kg/m(2), and 2,145 lung cancer deaths were recorded during 15 years of follow-up. The prevalence of smoking was strongly inversely associated with BMI, but no apparent relationship was seen between amount smoked (or other measures of smoking intensity) and BMI among smokers. Overall there was a strong inverse association between BMI and lung cancer mortality (p < 0.0001 for trend) after excluding the first 3 years of follow-up. This association appeared to be confined mainly to current smokers, with no apparent relationship in nonsmokers (p < 0.001 for difference between slopes). Among current smokers, the inverse association appeared to be log-linear, with each 5 kg/m(2) lower BMI associated with a 35% (95% confidence interval: 24-46%; p < 0.0001) higher lung cancer mortality, and it persisted after excluding those who had reported poor health status or history of any disease or respiratory symptoms at baseline. In this relatively lean Chinese male population, low BMI was strongly associated with increased risk of lung cancer only among current smokers. (c) 2009 UICC.

Entities:  

Mesh:

Year:  2009        PMID: 19585493     DOI: 10.1002/ijc.24527

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

Review 2.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

3.  Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival.

Authors:  Relin Yang; Michael C Cheung; Felipe E Pedroso; Margaret M Byrne; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Surg Res       Date:  2011-05-23       Impact factor: 2.192

4.  Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.

Authors:  Suzanne E Dahlberg; Joan H Schiller; Philip B Bonomi; Alan B Sandler; Julie R Brahmer; Suresh S Ramalingam; David H Johnson
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

5.  The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.

Authors:  Jay H Lubin; Michael B Cook; Nirmala Pandeya; Thomas L Vaughan; Christian C Abnet; Carol Giffen; Penelope M Webb; Liam J Murray; Alan G Casson; Harvey A Risch; Weimin Ye; Farin Kamangar; Leslie Bernstein; Linda Sharp; Olof Nyrén; Marilie D Gammon; Douglas A Corley; Anna H Wu; Linda M Brown; Wong-Ho Chow; Mary H Ward; Neal D Freedman; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2012-04-13       Impact factor: 2.984

6.  Body mass index and risk of lung cancer among never, former, and current smokers.

Authors:  Llewellyn Smith; Louise A Brinton; Margaret R Spitz; Tram Kim Lam; Yikyung Park; Albert R Hollenbeck; Neal D Freedman; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2012-03-27       Impact factor: 13.506

7.  Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas.

Authors:  Bin Gao; Yihua Sun; Junhua Zhang; Yan Ren; Rong Fang; Xiangkun Han; Lei Shen; Xin-Yuan Liu; William Pao; Haiquan Chen; Hongbin Ji
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

8.  Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer.

Authors:  Cuimin Ding; Ruijuan Li; Ping Wang; Haiyan Fan; Zhanjun Guo
Journal:  Exp Ther Med       Date:  2012-02-17       Impact factor: 2.447

9.  Outcome of active anti-cancer treatment in elderly patients with advanced non-small cell lung cancer: A single center experience.

Authors:  Ji Hye Kim; Min Sun Ryu; Yon Ju Ryu; Jin Hwa Lee; Sung Shine Shim; Yookyung Kim; Jung Hyun Chang
Journal:  Thorac Cancer       Date:  2014-03-03       Impact factor: 3.500

10.  Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study.

Authors:  W-P Koh; J-M Yuan; R Wang; H-P Lee; M C Yu
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.